Magnova 250 mg/31.25 mg Injection

Explore detailed information about Magnova 250 mg/31.25 mg Injection, a medication containing Cefepime (250mg) + Tazobactum (31.25mg) from the trusted Lupin Ltd brand. Discover its primary uses for Bacterial infections and delve deeper into its specific details to understand how Magnova 250 mg/31.25 mg Injection can play a role in your health and well-being. Add it to your wishlist or compare it with other products.

MRP: ₹ 138.35
Packing: 1.0 Injection in 1 vial
Salt Combination: Cefepime (250mg) + Tazobactum (31.25mg)
Brand: Lupin Ltd
Uses: Bacterial infections

Description

Magnova 250 mg/31.25 mg Injection is a combination of two antibiotics
It is prescribed to treat various types of bacterial infections
It fights against the infection by preventing the growth of microorganisms
Magnova 250 mg/31.25 mg Injection should only be administered under the supervision of a healthcare professional
Do not miss any scheduled appointments for taking this medicine
The course of the medicine should be completed even if you feel better.
The common side effects of this medicine are nausea, vomiting, diarrhea, rashes, etc
You may also experience injection site redness, swelling, and pain that goes away with time
If any of the side effects get aggravated, you must consult your doctor immediately
If you experience any allergic reaction (rashes, itching, swelling, shortness of breath, etc.), you must seek immediate medical help.
Before taking this medicine, you should tell your doctor if you are taking any medicines for any health condition
Pregnant or breastfeeding women should also consult with their doctor before taking it
Avoid drinking alcohol as it can cause excessive drowsiness with this medicine
It usually does not impair your ability to drive, but you should not drive if it makes you feel sleepy or dizzy.

Cautions

Liver:	SAFE IF PRESCRIBED: Magnova 250 mg/31.25 mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Magnova 250 mg/31.25 mg Injection may not be needed in these patients. Please consult your doctor.
Kidney:	CAUTION: Magnova 250 mg/31.25 mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Magnova 250 mg/31.25 mg Injection may be needed. Please consult your doctor.
Driving:	UNSAFE: Magnova 250 mg/31.25 mg Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Breast feeding:	SAFE IF PRESCRIBED: Magnova 250 mg/31.25 mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnency:	SAFE IF PRESCRIBED: Magnova 250 mg/31.25 mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Alcohol:	CAUTION: Caution is advised when consuming alcohol with Magnova 250 mg/31.25 mg Injection. Please consult your doctor.
Drug Action:	N/A
Therapeutic class:	ANTI INFECTIVES
Habit Forming:	No
Chemical Class:	N/A

Uses of Magnova 250 mg/31.25 mg Injection

In Bacterial infections Magnova 250 mg/31.25 mg Injection contains two different medicines, Cefepime and Tazobactum, that work together to kill the bacteria that cause infections
Cefipime works by stopping the growth of bacteria
Tazobactum reduces resistance and enhances the activity of Cefipime against bacteria
Magnova 250 mg/31.25 mg Injection can be used to treat many different bacterial infections
This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.